NCT04137627View on ClinicalTrials.gov

Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 4, 2017

Primary Completion Date

July 30, 2018

Study Completion Date

December 18, 2018

Conditions

Oral Squamous Cell CarcinomaNeoadjuvant Chemotherapy

Interventions

DRUG

Melatonin 20 MG Oral Capsule

The administration of Melatonin 20 mg in addition to neoadjuvant chemotherapy to observe the antioxidant and onco-static effect.

DRUG

Placebo oral capsule

The administration of placebo capsule in addition to neoadjuvant chemotherapy

Trial Locations (1)

10430

Faculty of Medicine, Universitas Indonesia, Jakarta Pusat

All Listed Sponsors

lead

Indonesia University

OTHER

NCT04137627 - Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter